To quantify ITF2 promoter methylation levels in both normal mucosa and CRC tumor tissue we tested 47 randomly selected normal-tumor pairs from Ontario and Newfoundland CRC cases, of which 12 were MSI-H and 35 were MSS. This evidence concerns the gene TCF4 and colorectal carcinoma.